US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Updates in Spinal-Bulbar Muscular Atrophy (SBMA)

Activity Snapshot

Activity Type: 
Live, Virtual Webinar
Release Date: 
Wednesday, July 10, 2024

Faculty

Christopher Grunseich
MD
National Institute of Neurological Disorders and Stroke, Lasker Investigator, National Institutes of Health